Direkt zum Inhalt
Merck
  • Potential insulin secretagogue effects of isovitexin and swertisin isolated from Wilbrandia ebracteata roots in non-diabetic rats.

Potential insulin secretagogue effects of isovitexin and swertisin isolated from Wilbrandia ebracteata roots in non-diabetic rats.

Fitoterapia (2010-08-04)
Poliane Folador, Luisa Helena Cazarolli, Andressa Córneo Gazola, Flávio Henrique Reginatto, Eloir Paulo Schenkel, Fátima Regina Mena Barreto Silva
ZUSAMMENFASSUNG

The antihyperglycemic effect and mechanism of action of extracts, fractions and compounds from Wilbrandia ebracteata was studied. The crude extract reduced the glycemia, increased glycogen content and serum insulin in hyperglycemic rats. Also, a significant effect was observed with the n-butanol and metanol subfraction. However, the antihyperglycemic effect of the n-butanol fraction was not observed in diabetic rats. The C-glycosylflavones isovitexin and swertisin showed a strong antihyperglycemic action compared with the extracts and fractions. These results show that the extracts, fractions, and isolated C-glycosylflavones have an antihyperglycemic action that was reinforced by the stimulation on in vivo insulin secretion.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Isovitexin, ≥98.0% (HPLC)
Isovitexin, primary reference standard